BRANFORD, Conn., June 27, 2012 (GLOBE NEWSWIRE) -- CAS Medical Systems,
Inc. (Nasdaq:CASM) (CASMED) today announced that Thomas Patton, Chief
Executive Officer, will present to investors as part of the 7th LHA
Life Sciences & Medical Technologies Virtual Conference on Thursday,
June 28, 2012 at 9:00 a.m. Eastern Time.

The presentation will be accessible live and for the next 90 days at
the PrecisionIR event website
www.investorcalendar.com/IC/CEPage.asp?ID=168963 or at the Company's
website www.casmed.com.

This day-long virtual conference event includes 30-minute presentations
with accompanying slides from seven industry leaders, and begins at
9:00 a.m. Eastern Time.

About CASMED(R) -- Monitoring What's Vital

CASMED is a leading developer and manufacturer of medical devices for
non-invasive patient monitoring. The Company's FORE-SIGHT(R) Absolute
Cerebral Oximeter provides a highly accurate, non-invasive, continuous
measurement of absolute cerebral tissue oxygen saturation. Direct
monitoring of tissue oxygenation provides a superior and powerful tool
to alert clinicians to otherwise unrecognized and dangerously low
levels of oxygenation of the brain and other tissues, thereby allowing
them to intervene appropriately in the care of their patients. In
addition to FORE-SIGHT(R) Oximeters and accessories, the Company
provides a line of bedside patient vital signs monitoring products,
proprietary non-invasive blood pressure monitoring solutions for OEM
use, neonatal intensive care supplies, and service. CASMED products are
designed to provide unique monitoring solutions that are vital to
patient care.

For further information regarding CASMED, visit the Company's website
at www.casmed.com.

Statements included in this press release, which are not historical in
nature, are forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Statements relating to the future performance of the Company are
subject to many factors including, but not limited to, the customer
acceptance of the products in the market, the introduction of
competitive products and product development, the impact of any product
liability or other adverse litigation, working capital and availability
of capital, commercialization and technological difficulties, the
impact of actions and events involving key customers, vendors, lenders
and competitors and other risks detailed in the Company's Form 10-K for
the year ended December 31, 2011 and other subsequent Securities and
Exchange Commission filings.

Such statements are based upon the current beliefs and expectations of
the Company's management and are subject to significant risks and
uncertainties. Actual results may differ from those set forth in the
forward-looking statements. When used in this press release the terms
"anticipate", "believe", "estimate", "expect", "may", "objective",
"plan", "possible", "potential", "project", "will" and similar
expressions identify forward-looking statements. The forward-looking
statements contained in this press release are made as of the date
hereof, and we do not undertake any obligation to update any
forward-looking statements, whether as a result of future events, new
information or otherwise.


CONTACT: Company Contact
         CAS Medical Systems, Inc.
         Jeffery Baird
         Chief Financial Officer
         (203) 315-6303
         ir@casmed.com
         
         Investors
         LHA
         Kim Sutton Golodetz (kgolodetz@lhai.com)
         (212) 838-3777
         Bruce Voss (bvoss@lhai.com)
         (310) 691-7100
         @LHA_IR_PR